Back to Search Start Over

Malignant Arrhythmogenic Role Associated with RBM20: A Comprehensive Interpretation Focused on a Personalized Approach

Authors :
Jordà, Paloma
Toro, Rocío
Diez, Carles
Salazar-Mendiguchía, Joel
Fernandez-Falgueras, Anna
Perez-Serra, Alexandra
Coll, Monica
Puigmulé, Marta
Arbelo, Elena
García-Álvarez, Ana
Sarquella-Brugada, Georgia
Cesar, Sergi
Tiron, Coloma
Iglesias, Anna
Brugada, Josep
Brugada, Ramon
Campuzano, Oscar
[Jordà,P
Arbelo,E
García-Álvarez,A
Brugada,J] Cardiology Department, Hospital Clinic, University of Barcelona-IDIBAPS, Barcelona, Spain. [Toro,R] Medicine Department, School of Medicine, University of Cadiz, Cadiz, Spain. [Toro,R] Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cadiz, Spain. [Diez,C
Salazar-Mendiguchía,J] Cardiovascular Diseases Research Group Bellvitge Biomedical Research Institute (IDIBELL) Hospitalet de Llobregat, Barcelona, Spain. [Diez,C] Advanced Heart Failure and Heart Transplant Unit Department of Cardiology Bellvitge University Hospital Hospitalet de Llobregat, Barcelona, Spain. [Fernandez-Falgueras,A
Perez-Serra,A
Coll,M
Puigmulé,M
Iglesias,A
Brugada,R
Campuzano,O] Cardiovascular Genetics Center, University of Girona-IDIBGI, Girona, Spain. [Perez-Serra,A
Brugada,J
Campuzano,O] Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. [Sarquella-Brugada,G
Cesar,S
Campuzano,O] Pediatric Arrhythmias, Inherited Cardiac Diseases and Sudden Death Unit, Cardiology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain. [Sarquella-Brugada,G
Campuzano,O] Medical Science Department, School of Medicine, University of Girona, Girona, Spain. [Tiron,C
Brugada,R] Cardiology Service, Hospital Josep Trueta, University of Girona, Girona, Spain.
This work was supported by Obra Social 'La Caixa Foundation' (LCF/PR/GN16/50290001 and LCF/PR/GN19/50320002), Fondo Investigacion Sanitaria (FIS PI16/01203 and FIS, PI17/01690) from Instituto Salud Carlos III (ISCIII), and 'Fundacio Privada Daniel Bravo Andreu'. CIBERCV is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness.
Publication Year :
2021
Publisher :
MDPI, 2021.

Abstract

The RBM20 gene encodes the muscle-specific splicing factor RNA-binding motif 20, a regulator of heart-specific alternative splicing. Nearly 40 potentially deleterious variants in RBM20 have been reported in the last ten years, being found to be associated with highly arrhythmogenic events in familial dilated cardiomyopathy. Frequently, malignant arrhythmias can be a primary manifestation of disease. The early recognition of arrhythmic genotypes is crucial in avoiding lethal episodes, as it may have an impact on the adoption of personalized preventive measures. Our study performs a comprehensive update of data concerning rare variants in RBM20 that are associated with malignant arrhythmogenic phenotypes with a focus on personalized medicine. Yes

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......2636..a24bea9656ad530c2e2376dccd6c95bb